General Information


DRACP ID  DRACP04078

Peptide Name  

Sequence  CASYFCRWWWAA

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C75H92N18O15S2

Absent amino acids  DEGHIKLMNPQTV

Common amino acids  AW

Mass  174618

Pl  8.22

Basic residues  1

Acidic residues  0

Hydrophobic residues  7

Net charge  1

Boman Index  -50

Hydrophobicity  32.5

Aliphatic Index  25

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  18115

Absorbance 280nm  1646.82

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33042031

Title  Hybrid Antimicrobial Peptide Targeting Staphylococcus aureu s and Displaying Anti-infective Activity in a Murine Model

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16901

DRACP is developed by Dr.Zheng's team.